⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for asp8273

Every month we try and update this database with for asp8273 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
An Open Study of ASP8273 in Patients With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) MutationsNCT02192697
Non-small Cell ...
ASP8273
20 Years - Astellas Pharma Inc
A Study for Subjects Who Are Participating in an Astellas-sponsored ASP8273 StudyNCT03042013
Subjects With N...
ASP8273
18 Years - Astellas Pharma Inc
A Study of ASP8273 in Subjects With Non-small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) MutationsNCT03082300
Non-small Cell ...
Epidermal Growt...
naquotinib
18 Years - Astellas Pharma Inc
A Study of ASP8273 in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-Naïve Patients With Non-Small Cell Lung Cancer Harboring EGFR MutationsNCT02500927
EGFR-TKI-naïve ...
ASP8273 Capsule...
ASP8273 Capsule...
20 Years - Astellas Pharma Inc
A Study for Subjects Who Are Participating in an Astellas-sponsored ASP8273 StudyNCT03042013
Subjects With N...
ASP8273
18 Years - Astellas Pharma Inc
A Study of ASP8273 vs. Erlotinib or Gefitinib in First-line Treatment of Patients With Stage IIIB/IV Non-small Cell Lung Cancer Tumors With EGFR Activating MutationsNCT02588261
Non-small Cell ...
naquotinib mesi...
Erlotinib
Gefitinib
18 Years - Astellas Pharma Inc
A Study of ASP8273 vs. Erlotinib or Gefitinib in First-line Treatment of Patients With Stage IIIB/IV Non-small Cell Lung Cancer Tumors With EGFR Activating MutationsNCT02588261
Non-small Cell ...
naquotinib mesi...
Erlotinib
Gefitinib
18 Years - Astellas Pharma Inc
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: